메뉴 건너뛰기




Volumn 25, Issue 10, 2007, Pages 1824-1837

GRA1 protein vaccine confers better immune response compared to codon-optimized GRA1 DNA vaccine

Author keywords

Adjuvanted recombinant protein vaccination; Codon optimization; DNA vaccination; GRA1; Toxoplasma gondii

Indexed keywords

ADJUVANT; CYTOKINE; DNA VACCINE; GAMMA INTERFERON; GRA1 DNA VACINE; GRA1 PROTEIN VACCINE; IMMUNOGLOBULIN G; INTERLEUKIN 4; PROVAX; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

EID: 33846582988     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2006.10.060     Document Type: Article
Times cited : (32)

References (64)
  • 1
  • 2
    • 33846600146 scopus 로고    scopus 로고
    • National Institute of Allergy and Infectious Diseases Biodefense Research Agenda for Category B and C Priority Pathogens, June 2003 [Online]. http://www3.niaid.nih.gov/Biodefense/Research/categorybandc.pdf. Assessed 1 April 2006.
  • 3
    • 0345016346 scopus 로고    scopus 로고
    • From cells to signaling cascades: manipulation of innate immunity by Toxoplasma gondii
    • Denkers E.Y. From cells to signaling cascades: manipulation of innate immunity by Toxoplasma gondii. FEMS Immunol Med Microbiol 39 (2003) 193-203
    • (2003) FEMS Immunol Med Microbiol , vol.39 , pp. 193-203
    • Denkers, E.Y.1
  • 4
    • 33846589029 scopus 로고    scopus 로고
    • Vaccines and vaccination
    • Pier G.B., Lyczak J.B., and Wetzler L.M. (Eds), American Society for Microbiology, Washington, D.C
    • Pier G.B. Vaccines and vaccination. In: Pier G.B., Lyczak J.B., and Wetzler L.M. (Eds). Immunology, infection, and immunity (2004), American Society for Microbiology, Washington, D.C 497-528
    • (2004) Immunology, infection, and immunity , pp. 497-528
    • Pier, G.B.1
  • 5
    • 0031736936 scopus 로고    scopus 로고
    • Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection
    • Denkers E.Y., and Gazzinelli R.T. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev 11 (1998) 569-588
    • (1998) Clin Microbiol Rev , vol.11 , pp. 569-588
    • Denkers, E.Y.1    Gazzinelli, R.T.2
  • 6
    • 0038665562 scopus 로고    scopus 로고
    • Development of a vaccine for toxoplasmosis: current status
    • Bhopale G.M. Development of a vaccine for toxoplasmosis: current status. Mic Infect 5 (2003) 457-462
    • (2003) Mic Infect , vol.5 , pp. 457-462
    • Bhopale, G.M.1
  • 7
    • 0033958903 scopus 로고    scopus 로고
    • Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents
    • Angus C.W., Klivington-Evans D., Dubey J.P., and Kovacs J.A. Immunization with a DNA plasmid encoding the SAG1 (P30) protein of Toxoplasma gondii is immunogenic and protective in rodents. J Infect Dis 181 (2000) 317-324
    • (2000) J Infect Dis , vol.181 , pp. 317-324
    • Angus, C.W.1    Klivington-Evans, D.2    Dubey, J.P.3    Kovacs, J.A.4
  • 8
    • 0141888319 scopus 로고    scopus 로고
    • Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studies
    • Bivas-Benita M., Laloup M., Versteyhe S., Dewit J., De Braekeleer J., Jongert E., et al. Generation of Toxoplasma gondii GRA1 protein and DNA vaccine loaded chitosan particles: preparation, characterization, and preliminary in vivo studies. Int J Pharm 266 (2003) 17-27
    • (2003) Int J Pharm , vol.266 , pp. 17-27
    • Bivas-Benita, M.1    Laloup, M.2    Versteyhe, S.3    Dewit, J.4    De Braekeleer, J.5    Jongert, E.6
  • 9
    • 0035112117 scopus 로고    scopus 로고
    • Intranasal immunization with SAG1 nontoxic mutant heat labile enterotoxins protects mice against Toxoplasma gondii
    • Bonenfant C., Dimier-Poisson I., Velge-Roussel F., Buzoni-Gatel D., Del Giudice G., Rappuoli R., et al. Intranasal immunization with SAG1 nontoxic mutant heat labile enterotoxins protects mice against Toxoplasma gondii. Infect Immun 69 (2001) 1605-1612
    • (2001) Infect Immun , vol.69 , pp. 1605-1612
    • Bonenfant, C.1    Dimier-Poisson, I.2    Velge-Roussel, F.3    Buzoni-Gatel, D.4    Del Giudice, G.5    Rappuoli, R.6
  • 10
    • 0038513466 scopus 로고    scopus 로고
    • DNA vaccination with the immunodominant tachyzoite surface antigen (SAG-1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofoetal transmission
    • Couper K.N., Nielsen H.V., Petersen E., Roberts F., Roberts C.W., and Alexander J. DNA vaccination with the immunodominant tachyzoite surface antigen (SAG-1) protects against adult acquired Toxoplasma gondii infection but does not prevent maternofoetal transmission. Vaccine 21 (2003) 2813-2820
    • (2003) Vaccine , vol.21 , pp. 2813-2820
    • Couper, K.N.1    Nielsen, H.V.2    Petersen, E.3    Roberts, F.4    Roberts, C.W.5    Alexander, J.6
  • 11
    • 0343674744 scopus 로고    scopus 로고
    • Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene
    • Desolme B., Mevelec M.N., Buzoni-Gatel D., and Bout D. Induction of protective immunity against toxoplasmosis in mice by DNA immunization with a plasmid encoding Toxoplasma gondii GRA4 gene. Vaccine 18 (2000) 2512-2521
    • (2000) Vaccine , vol.18 , pp. 2512-2521
    • Desolme, B.1    Mevelec, M.N.2    Buzoni-Gatel, D.3    Bout, D.4
  • 12
    • 0037471350 scopus 로고    scopus 로고
    • Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice
    • Fachado A., Rodriguez A., and Angel S.O. Protective effect of a naked DNA vaccine cocktail against lethal toxoplasmosis in mice. Vaccine 21 (2003) 1327-1335
    • (2003) Vaccine , vol.21 , pp. 1327-1335
    • Fachado, A.1    Rodriguez, A.2    Angel, S.O.3
  • 13
    • 0041322584 scopus 로고    scopus 로고
    • Long-term protective immune response elicited by vaccination with an expression genomic library of Toxoplasma gondii
    • Fachado A., Rodriguez A., Molina J., Silverio J.C., Marino A.P., Pinto L.M., et al. Long-term protective immune response elicited by vaccination with an expression genomic library of Toxoplasma gondii. Infect Immun 71 (2003) 5407-5411
    • (2003) Infect Immun , vol.71 , pp. 5407-5411
    • Fachado, A.1    Rodriguez, A.2    Molina, J.3    Silverio, J.C.4    Marino, A.P.5    Pinto, L.M.6
  • 14
    • 0033855638 scopus 로고    scopus 로고
    • Protective immunity against congenital toxoplasmosis with recombinant SAG1 protein in a Guinea pig model
    • Haumont M.L., Delhaye L., Garcia M., Jurado P., Mazza V., Daminet V., et al. Protective immunity against congenital toxoplasmosis with recombinant SAG1 protein in a Guinea pig model. Infect Immun 68 (2000) 4948-4953
    • (2000) Infect Immun , vol.68 , pp. 4948-4953
    • Haumont, M.L.1    Delhaye, L.2    Garcia, M.3    Jurado, P.4    Mazza, V.5    Daminet, V.6
  • 15
    • 0242349654 scopus 로고    scopus 로고
    • The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis
    • Ismael A.B., Sekkai D., Collin C., Bout D., and Mevelec M.N. The MIC3 gene of Toxoplasma gondii is a novel potent vaccine candidate against toxoplasmosis. Infect Immun 71 (2003) 6222-6228
    • (2003) Infect Immun , vol.71 , pp. 6222-6228
    • Ismael, A.B.1    Sekkai, D.2    Collin, C.3    Bout, D.4    Mevelec, M.N.5
  • 16
    • 0031710771 scopus 로고    scopus 로고
    • Protective effect of vaccination with a combination of recombinant surface antigen 1 and interleukin 12 against toxoplasmosis in mice
    • Letscher-Bru V., Villard O., Risse B., Zauke M., Klein J.P., and Kien T.T. Protective effect of vaccination with a combination of recombinant surface antigen 1 and interleukin 12 against toxoplasmosis in mice. Infect Immun 66 (1998) 4503-4506
    • (1998) Infect Immun , vol.66 , pp. 4503-4506
    • Letscher-Bru, V.1    Villard, O.2    Risse, B.3    Zauke, M.4    Klein, J.P.5    Kien, T.T.6
  • 17
    • 0242381191 scopus 로고    scopus 로고
    • Vaccination with Toxoplasma gondii SAG-1 protein is protective against congenital toxoplasmosis in BALB/c mice but not in CBA/J mice
    • Letscher-Bru V., Pfaff A.W., Abou-Bacar A., Filisetti D., Antoni E., Villard O., et al. Vaccination with Toxoplasma gondii SAG-1 protein is protective against congenital toxoplasmosis in BALB/c mice but not in CBA/J mice. Infect Immun 71 (2003) 6615-6619
    • (2003) Infect Immun , vol.71 , pp. 6615-6619
    • Letscher-Bru, V.1    Pfaff, A.W.2    Abou-Bacar, A.3    Filisetti, D.4    Antoni, E.5    Villard, O.6
  • 18
    • 0034910058 scopus 로고    scopus 로고
    • Genetic immunization with plasmid DNA coding for the ROP2 protein of Toxoplasma gondii
    • Leyva R., Herion P., and Saavedra R. Genetic immunization with plasmid DNA coding for the ROP2 protein of Toxoplasma gondii. Parasitol Res 87 (2001) 70-79
    • (2001) Parasitol Res , vol.87 , pp. 70-79
    • Leyva, R.1    Herion, P.2    Saavedra, R.3
  • 19
    • 3242660937 scopus 로고    scopus 로고
    • Recombinant GRA4 or ROP2 protein combined with alum or the GRA4 gene provides partial protection in chronic murine models of toxoplasmosis
    • Martin V., Supanitsky A., Echeverria P.C., Litwin S., Tanos T., De Roodt A.R., et al. Recombinant GRA4 or ROP2 protein combined with alum or the GRA4 gene provides partial protection in chronic murine models of toxoplasmosis. Clin Diagn Lab Immunol 11 (2004) 704-710
    • (2004) Clin Diagn Lab Immunol , vol.11 , pp. 704-710
    • Martin, V.1    Supanitsky, A.2    Echeverria, P.C.3    Litwin, S.4    Tanos, T.5    De Roodt, A.R.6
  • 20
    • 22044439728 scopus 로고    scopus 로고
    • Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice
    • Mevelec M.N., Bout D., Desolme B., Marchand H., Magne R., Bruneel O., et al. Evaluation of protective effect of DNA vaccination with genes encoding antigens GRA4 and SAG1 associated with GM-CSF plasmid, against acute, chronical and congenital toxoplasmosis in mice. Vaccine 23 (2005) 4489-4499
    • (2005) Vaccine , vol.23 , pp. 4489-4499
    • Mevelec, M.N.1    Bout, D.2    Desolme, B.3    Marchand, H.4    Magne, R.5    Bruneel, O.6
  • 21
    • 0035321583 scopus 로고    scopus 로고
    • Modified protection against Toxoplasma gondii lethal infection and brain cyst formation by vaccination with SAG2 and SRS1
    • Mishima M., Xuan X., Shioda A., Omata Y., Fujisaki K., Nagasawa H., et al. Modified protection against Toxoplasma gondii lethal infection and brain cyst formation by vaccination with SAG2 and SRS1. J Vet Med Sci 63 (2001) 433-438
    • (2001) J Vet Med Sci , vol.63 , pp. 433-438
    • Mishima, M.1    Xuan, X.2    Shioda, A.3    Omata, Y.4    Fujisaki, K.5    Nagasawa, H.6
  • 22
    • 0037836948 scopus 로고    scopus 로고
    • Induction of protective immunity by DNA vaccination with Toxoplasma gondii HSP70, HSP30 and SAG1 genes
    • Mohamed R.M., Aosai F., Chen M., Mun H.S., Norose K., Belal U.S., et al. Induction of protective immunity by DNA vaccination with Toxoplasma gondii HSP70, HSP30 and SAG1 genes. Vaccine 21 (2003) 2852-2861
    • (2003) Vaccine , vol.21 , pp. 2852-2861
    • Mohamed, R.M.1    Aosai, F.2    Chen, M.3    Mun, H.S.4    Norose, K.5    Belal, U.S.6
  • 23
    • 0032702582 scopus 로고    scopus 로고
    • Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene
    • Nielsen H.V., Lauemoller S.L., Christiansen L., Buus S., Fomsgaard A., and Petersen E. Complete protection against lethal Toxoplasma gondii infection in mice immunized with a plasmid encoding the SAG1 gene. Infect Immun 67 (1999) 6358-6363
    • (1999) Infect Immun , vol.67 , pp. 6358-6363
    • Nielsen, H.V.1    Lauemoller, S.L.2    Christiansen, L.3    Buus, S.4    Fomsgaard, A.5    Petersen, E.6
  • 24
    • 0032146449 scopus 로고    scopus 로고
    • Immunization with E. coli produced recombinant T. gondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii
    • Petersen E., Henrik V.N., Christiansen L., and Spenter J. Immunization with E. coli produced recombinant T. gondii SAG1 with alum as adjuvant protect mice against lethal infection with Toxoplasma gondii. Vaccine 16 (1998) 1283-1289
    • (1998) Vaccine , vol.16 , pp. 1283-1289
    • Petersen, E.1    Henrik, V.N.2    Christiansen, L.3    Spenter, J.4
  • 25
    • 2442492088 scopus 로고    scopus 로고
    • MVA ROP2 vaccinia virus recombinant as a vaccine candidate for toxoplasmosis
    • Roque-Resendiz J.L., Rosales R., and Herion P. MVA ROP2 vaccinia virus recombinant as a vaccine candidate for toxoplasmosis. Parasitology 128 (2004) 397-405
    • (2004) Parasitology , vol.128 , pp. 397-405
    • Roque-Resendiz, J.L.1    Rosales, R.2    Herion, P.3
  • 26
    • 0037220935 scopus 로고    scopus 로고
    • A GRA1 DNA vaccine primes cytolytic CD8_T cells to control acute Toxoplasma gondii infection
    • Scorza T., D'Souza S., Laloup M., Dewit J., De Braekeleer J., Verschueren H., et al. A GRA1 DNA vaccine primes cytolytic CD8_T cells to control acute Toxoplasma gondii infection. Infect Immun 71 (2003) 309-316
    • (2003) Infect Immun , vol.71 , pp. 309-316
    • Scorza, T.1    D'Souza, S.2    Laloup, M.3    Dewit, J.4    De Braekeleer, J.5    Verschueren, H.6
  • 27
    • 0033605234 scopus 로고    scopus 로고
    • Immunogenicity of recombinant BCG producing the GRA1 antigen from Toxoplasma gondii
    • Supply P., Sutton P., Coughlan S.N., Bilo K., Saman E., Trees A.J., et al. Immunogenicity of recombinant BCG producing the GRA1 antigen from Toxoplasma gondii. Vaccine 17 (1999) 705-714
    • (1999) Vaccine , vol.17 , pp. 705-714
    • Supply, P.1    Sutton, P.2    Coughlan, S.N.3    Bilo, K.4    Saman, E.5    Trees, A.J.6
  • 28
    • 0033961350 scopus 로고    scopus 로고
    • DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7 and ROP2 induces partially protective immunity against lethal challenge in mice
    • Vercammen M., Scorza T., Huygen K., De Braekeleer J., Diet R., Jacobs D., et al. DNA vaccination with genes encoding Toxoplasma gondii antigens GRA1, GRA7 and ROP2 induces partially protective immunity against lethal challenge in mice. Infect Immun 68 (2000) 38-45
    • (2000) Infect Immun , vol.68 , pp. 38-45
    • Vercammen, M.1    Scorza, T.2    Huygen, K.3    De Braekeleer, J.4    Diet, R.5    Jacobs, D.6
  • 29
    • 0842308891 scopus 로고    scopus 로고
    • Protective immunity against Toxoplasma gondii in mice induced by a chimeric protein rSAG1/2
    • Yang C.D., Chang G.N., and Chao D. Protective immunity against Toxoplasma gondii in mice induced by a chimeric protein rSAG1/2. Parasitol Res 92 (2004) 58-64
    • (2004) Parasitol Res , vol.92 , pp. 58-64
    • Yang, C.D.1    Chang, G.N.2    Chao, D.3
  • 30
    • 0022002191 scopus 로고
    • An unexpected response to vaccination with a purified major membrane tachyzoite antigen (P30) of Toxoplasma gondii
    • Kasper L.H., Currie K.M., and Bradley M.S. An unexpected response to vaccination with a purified major membrane tachyzoite antigen (P30) of Toxoplasma gondii. J Immunol 134 (1985) 3426-3431
    • (1985) J Immunol , vol.134 , pp. 3426-3431
    • Kasper, L.H.1    Currie, K.M.2    Bradley, M.S.3
  • 31
    • 18744377482 scopus 로고    scopus 로고
    • Toxoplasma gondii antigens GRA1 (p24) and SAG1 (p30): a comparison of their stimulatory influence on T-cell activation and cytokine expression in in vitro cultures
    • Kato M., Claveria F.G., Maki Y., Tanaka T., Suzuki N., and Nagasawa H. Toxoplasma gondii antigens GRA1 (p24) and SAG1 (p30): a comparison of their stimulatory influence on T-cell activation and cytokine expression in in vitro cultures. Pathobiology 72 (2005) 160-164
    • (2005) Pathobiology , vol.72 , pp. 160-164
    • Kato, M.1    Claveria, F.G.2    Maki, Y.3    Tanaka, T.4    Suzuki, N.5    Nagasawa, H.6
  • 32
    • 0033588526 scopus 로고    scopus 로고
    • Novel aggregate structure adjuvants modulate lymphocyte proliferation and Th1 and Th2 cytokine profiles in ovalbumin immunized mice
    • Rajananthanan P., Attard G.S., Sheikh N.A., and Morrow W.J. Novel aggregate structure adjuvants modulate lymphocyte proliferation and Th1 and Th2 cytokine profiles in ovalbumin immunized mice. Vaccine 18 (1999) 140-152
    • (1999) Vaccine , vol.18 , pp. 140-152
    • Rajananthanan, P.1    Attard, G.S.2    Sheikh, N.A.3    Morrow, W.J.4
  • 33
    • 0242317692 scopus 로고    scopus 로고
    • Differential requirements for CTL generation by novel immunostimulants: APC tropism, use of the TAP-independent processing pathway, and dependency on CD80/CD86 costimulation
    • Sheikh N.A., Attard G.S., van Rooijen N., Rajananthanan P., Hariharan K., Yang Y.W., et al. Differential requirements for CTL generation by novel immunostimulants: APC tropism, use of the TAP-independent processing pathway, and dependency on CD80/CD86 costimulation. Vaccine 21 (2003) 3775-3788
    • (2003) Vaccine , vol.21 , pp. 3775-3788
    • Sheikh, N.A.1    Attard, G.S.2    van Rooijen, N.3    Rajananthanan, P.4    Hariharan, K.5    Yang, Y.W.6
  • 34
    • 0031906148 scopus 로고    scopus 로고
    • Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage
    • Andre S., Seed B., Eberle J., Schraut W., Bultmann A., and Haas J. Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage. J Virol 72 (1998) 1497-1503
    • (1998) J Virol , vol.72 , pp. 1497-1503
    • Andre, S.1    Seed, B.2    Eberle, J.3    Schraut, W.4    Bultmann, A.5    Haas, J.6
  • 35
    • 0036132824 scopus 로고    scopus 로고
    • Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol gene
    • Casimiro D.R., Tang A., Perry H.C., Long R.S., Chen M., Heidecker G.J., et al. Vaccine-induced immune responses in rodents and nonhuman primates by use of a humanized human immunodeficiency virus type 1 pol gene. J Virol 76 (2002) 185-194
    • (2002) J Virol , vol.76 , pp. 185-194
    • Casimiro, D.R.1    Tang, A.2    Perry, H.C.3    Long, R.S.4    Chen, M.5    Heidecker, G.J.6
  • 36
    • 0034755765 scopus 로고    scopus 로고
    • Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein
    • Deml L., Bojak A., Steck S., Graf M., Wild J., Schirmbeck R., et al. Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein. J Virol 75 (2001) 10991-11001
    • (2001) J Virol , vol.75 , pp. 10991-11001
    • Deml, L.1    Bojak, A.2    Steck, S.3    Graf, M.4    Wild, J.5    Schirmbeck, R.6
  • 37
    • 0038046535 scopus 로고    scopus 로고
    • Codon optimization of the HPV-16 E5 gene enhances protein expression
    • Disbrow G.L., Sunitha I., Baker C.C., Hanover J., and Schlegel R. Codon optimization of the HPV-16 E5 gene enhances protein expression. Virology 311 (2003) 105-114
    • (2003) Virology , vol.311 , pp. 105-114
    • Disbrow, G.L.1    Sunitha, I.2    Baker, C.C.3    Hanover, J.4    Schlegel, R.5
  • 38
    • 0036022161 scopus 로고    scopus 로고
    • Codon optimization improves heterologous expression of a Schistosoma mansoni cDNA in HEK293 cells
    • Hamdan F.F., Mousa A., and Ribeiro P. Codon optimization improves heterologous expression of a Schistosoma mansoni cDNA in HEK293 cells. Parasitol Res 88 (2002) 583-586
    • (2002) Parasitol Res , vol.88 , pp. 583-586
    • Hamdan, F.F.1    Mousa, A.2    Ribeiro, P.3
  • 39
    • 3242676308 scopus 로고    scopus 로고
    • Codon optimization of the human papillomavirus 11 (HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cells
    • Mossadegh N., Gissmann L., Muller M., Zentgraf H., Alonso A., and Tomakidi P. Codon optimization of the human papillomavirus 11 (HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cells. Virology 326 (2004) 57-66
    • (2004) Virology , vol.326 , pp. 57-66
    • Mossadegh, N.1    Gissmann, L.2    Muller, M.3    Zentgraf, H.4    Alonso, A.5    Tomakidi, P.6
  • 40
    • 0033516966 scopus 로고    scopus 로고
    • Codon optimization effect on translational efficiency of DNA vaccine in mammalian cells: analysis of plasmid DNA encoding a CTL epitope derived from microorganisms
    • Nagata T., Uchijima M., Yoshida A., Kawashima M., and Koide Y. Codon optimization effect on translational efficiency of DNA vaccine in mammalian cells: analysis of plasmid DNA encoding a CTL epitope derived from microorganisms. Biochem Biophys Res Commun 261 (1999) 445-451
    • (1999) Biochem Biophys Res Commun , vol.261 , pp. 445-451
    • Nagata, T.1    Uchijima, M.2    Yoshida, A.3    Kawashima, M.4    Koide, Y.5
  • 41
    • 0035190397 scopus 로고    scopus 로고
    • Codon optimization of gene fragments encoding Plasmodium falciparum merzoite proteins enhances DNA vaccine protein expression and immunogenicity in mice
    • Narum D.L., Kumar S., Rogers W.O., Fuhrmann S.R., Liang H., Oakley M., et al. Codon optimization of gene fragments encoding Plasmodium falciparum merzoite proteins enhances DNA vaccine protein expression and immunogenicity in mice. Infect Immun 69 (2001) 7250-7253
    • (2001) Infect Immun , vol.69 , pp. 7250-7253
    • Narum, D.L.1    Kumar, S.2    Rogers, W.O.3    Fuhrmann, S.R.4    Liang, H.5    Oakley, M.6
  • 42
    • 4143058116 scopus 로고    scopus 로고
    • Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization
    • Ramakrishna L., Anand K.K., Mohankumar K.M., and Ranga U. Codon optimization of the tat antigen of human immunodeficiency virus type 1 generates strong immune responses in mice following genetic immunization. J Virol 78 (2004) 9174-9189
    • (2004) J Virol , vol.78 , pp. 9174-9189
    • Ramakrishna, L.1    Anand, K.K.2    Mohankumar, K.M.3    Ranga, U.4
  • 45
    • 0032533471 scopus 로고    scopus 로고
    • Optimization of codon usage of plasmid DNA vaccine is required for the effective MHC class I-restricted T cell responses against an intracellular bacterium
    • Uchijima M., Yoshida A., Nagata T., and Koide Y. Optimization of codon usage of plasmid DNA vaccine is required for the effective MHC class I-restricted T cell responses against an intracellular bacterium. J Immunol 161 (1998) 5594-5599
    • (1998) J Immunol , vol.161 , pp. 5594-5599
    • Uchijima, M.1    Yoshida, A.2    Nagata, T.3    Koide, Y.4
  • 46
    • 0033597120 scopus 로고    scopus 로고
    • Gene gun DNA vaccination with Rev-independent synthetic HIV-1 gp160 envelope gene using mammalian codons
    • Vinner L., Nielsen H.V., Bryder K., Corbet S., Nielsen C., and Fomsgaard A. Gene gun DNA vaccination with Rev-independent synthetic HIV-1 gp160 envelope gene using mammalian codons. Vaccine 17 (1999) 2166-2175
    • (1999) Vaccine , vol.17 , pp. 2166-2175
    • Vinner, L.1    Nielsen, H.V.2    Bryder, K.3    Corbet, S.4    Nielsen, C.5    Fomsgaard, A.6
  • 47
    • 0034056240 scopus 로고    scopus 로고
    • Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene
    • zur Megede J., Chen M.C., Doe B., Schaefer M., Greer C.E., Selby M., et al. Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene. J Virol 74 (2000) 2628-2635
    • (2000) J Virol , vol.74 , pp. 2628-2635
    • zur Megede, J.1    Chen, M.C.2    Doe, B.3    Schaefer, M.4    Greer, C.E.5    Selby, M.6
  • 48
    • 20044369888 scopus 로고    scopus 로고
    • Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery
    • Davies D.H., Liang X., Hernandez J.E., Randall A., Hirst S., Mu Y., et al. Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proc Natl Acad Sci USA 102 (2005) 547-552
    • (2005) Proc Natl Acad Sci USA , vol.102 , pp. 547-552
    • Davies, D.H.1    Liang, X.2    Hernandez, J.E.3    Randall, A.4    Hirst, S.5    Mu, Y.6
  • 50
    • 0032490611 scopus 로고    scopus 로고
    • Development and application of PROVAX adjuvant formulation for subunit cancer vaccines
    • Hariharan K., and Hanna N. Development and application of PROVAX adjuvant formulation for subunit cancer vaccines. Adv Drug Deliv Rev 32 (1998) 187-197
    • (1998) Adv Drug Deliv Rev , vol.32 , pp. 187-197
    • Hariharan, K.1    Hanna, N.2
  • 51
    • 24644490503 scopus 로고    scopus 로고
    • Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice
    • Davies D.H., McCausland M.M., Valdez C., Huynh D., Hernandez J.E., Mu Y., et al. Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice. J Virol 79 (2005) 11724-11733
    • (2005) J Virol , vol.79 , pp. 11724-11733
    • Davies, D.H.1    McCausland, M.M.2    Valdez, C.3    Huynh, D.4    Hernandez, J.E.5    Mu, Y.6
  • 53
    • 0029042137 scopus 로고
    • A commercial vaccine for ovine toxoplasmosis
    • Buxton D., and Innes E.A. A commercial vaccine for ovine toxoplasmosis. Parasitology 110 (1995) 11-16
    • (1995) Parasitology , vol.110 , pp. 11-16
    • Buxton, D.1    Innes, E.A.2
  • 54
    • 33846640277 scopus 로고    scopus 로고
    • DNA vaccines
    • Levine M.M., Kaper J.B., Rappuoli R., Liu M.A., and Good M.F. (Eds), Marcel Dekker, New York
    • Kenney R.T., and Edelman R. DNA vaccines. In: Levine M.M., Kaper J.B., Rappuoli R., Liu M.A., and Good M.F. (Eds). New generation vaccines. 3rd ed. (2004), Marcel Dekker, New York 368-370
    • (2004) New generation vaccines. 3rd ed. , pp. 368-370
    • Kenney, R.T.1    Edelman, R.2
  • 55
    • 1442289362 scopus 로고    scopus 로고
    • Enhanced expression of a recombinant malaria candidate vaccine in Escherichia coli by codon optimization
    • Zhou Z., Schnake P., Xiao L., and Lal A.A. Enhanced expression of a recombinant malaria candidate vaccine in Escherichia coli by codon optimization. Protein Expr Purif 34 (2004) 87-94
    • (2004) Protein Expr Purif , vol.34 , pp. 87-94
    • Zhou, Z.1    Schnake, P.2    Xiao, L.3    Lal, A.A.4
  • 58
    • 0028169529 scopus 로고
    • Dense-granule organelles of Toxoplasma gondii
    • Cesbron-Delauw M.F. Dense-granule organelles of Toxoplasma gondii. Parasitol Today 10 (1994) 293-296
    • (1994) Parasitol Today , vol.10 , pp. 293-296
    • Cesbron-Delauw, M.F.1
  • 59
  • 60
    • 0032454584 scopus 로고    scopus 로고
    • Classification and evolution of EF-hand proteins
    • Kawasaki H., Nakayama S., and Kretsinger R.H. Classification and evolution of EF-hand proteins. Biometals 11 (1998) 277-295
    • (1998) Biometals , vol.11 , pp. 277-295
    • Kawasaki, H.1    Nakayama, S.2    Kretsinger, R.H.3
  • 61
    • 0025696273 scopus 로고
    • Goat testis calmodulin: purification and physicochemical characterization
    • Bandyopadhyay S., and Ghosh S.K. Goat testis calmodulin: purification and physicochemical characterization. J Protein Chem 9 (1990) 603-611
    • (1990) J Protein Chem , vol.9 , pp. 603-611
    • Bandyopadhyay, S.1    Ghosh, S.K.2
  • 62
    • 0022745564 scopus 로고
    • Identification of calmodulin in new-born rat calvaria
    • Tojyo Y., and Matsumoto Y. Identification of calmodulin in new-born rat calvaria. Biochem Int 13 (1986) 155-161
    • (1986) Biochem Int , vol.13 , pp. 155-161
    • Tojyo, Y.1    Matsumoto, Y.2
  • 63
    • 0032913345 scopus 로고    scopus 로고
    • Cloning and functional expression of the calmodulin gene from Toxoplasma gondii
    • Seeber F., Beuerle B., and Schmidt H.H. Cloning and functional expression of the calmodulin gene from Toxoplasma gondii. Mol Biochem Parasitol 99 (1999) 295-299
    • (1999) Mol Biochem Parasitol , vol.99 , pp. 295-299
    • Seeber, F.1    Beuerle, B.2    Schmidt, H.H.3
  • 64
    • 33749336826 scopus 로고    scopus 로고
    • Immunologic adjuvants
    • Plotkin S.A., and Orenstein W.A. (Eds), Saunders Elsevier Inc, Pennsylvania
    • Vogel F.R., and Hem S.L. Immunologic adjuvants. In: Plotkin S.A., and Orenstein W.A. (Eds). Vaccines. 4th ed. (2004), Saunders Elsevier Inc, Pennsylvania 69-79
    • (2004) Vaccines. 4th ed. , pp. 69-79
    • Vogel, F.R.1    Hem, S.L.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.